Single Scope Staging of Lung Cancer With Endosonography
NCT02014324 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 215
Last updated 2014-10-20
Summary
Rationale: Lung cancer is the most commonly diagnosed cancer worldwide and is the most frequent cause of cancer death. Accurate staging is important because it directs treatment and prognosis. Mediastinal staging can be done by both EBUS-TBNA and EUS-FNA. These two techniques have a complementary diagnostic range and the combined procedure is suited for assessment of almost the entire mediastinum. In practice, when mediastinal tissue staging is indicated, endoscopists often perform either an EBUS or an EUS investigation (instead of the combined procedure). Second, frequently only one or two, by imaging suspected lymph node stations, are sampled (ie. targeted approach).
Objectives: main and secondary:
1. Complete endosonographic (combined endobronchial and esophageal) staging using a single EBUS scope improves locoregional staging (N2, N3, T4) versus EBUS staging alone.
2. Systematic mediastinal staging results in improved locoregional staging compared to PET-CT directed assessment of the mediastinum (ie targeted approach).
Study population: Patients with potentially operable and resectable NSCLC are eligible if there is an indication for mediastinal nodal sampling. Patients have an indication for EBUS-TBNA.
Intervention: Patients will undergo an EBUS investigation followed by EUS-B in the same session. During this single scope procedure, lymph nodes that are suspected on prior CT-PET imaging and on subsequent ultrasound are sampled.
Main study endpoint: The main study parameter is the sensitivity for locoregional disease (N2, N3, T4 disease) of complete endosonographic staging (by EBUS-TBNA and EUS-B-FNA) in comparison with EBUS staging alone.
Conditions
- Non Small Cell Lung Cancer (NSCLC)
- Indication Mediastinal Staging
- Complete Endosonography
Interventions
- PROCEDURE
-
Endosonography
Complete endosonographic mediastinal staging is performed in 2 steps: 1. Systematic EBUS (airways) 2. Systematic EUS-B (esophagus)
Sponsors & Collaborators
-
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
lead OTHER
Principal Investigators
-
Jouke T Annema, MD, PhD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2014-10-31
- Completion
- 2014-10-31
Countries
- Belgium
- Netherlands
Study Locations
More Related Trials
-
Lung Cancer Diagnosis and Staging Using Ultrasound Guidance
NCT01623765 ·Status: COMPLETED
-
Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion
NCT05596578 ·Status: RECRUITING
-
Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
NCT01487603 ·Status: RECRUITING
-
The Role of Endobronchial Needle Aspiration With Rapid On-site Evaluation in the Diagnosis of Central Malignant Lesions
NCT01456741 ·Status: COMPLETED ·Phase: NA
-
Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer
NCT02991924 ·Status: ACTIVE_NOT_RECRUITING
-
Surgical Versus Non-surgical Staging of Lung Cancer
NCT01117714 ·Status: TERMINATED ·Phase: NA
-
The Diagnostic Value of Bronchoscopic Needle-based Confocal Laser Endomicroscopy (nCLE) As a Real-time Detection Tool for Diagnosing Peripheral Lung Cancer: a Multi-centre Randomised Controlled Trial
NCT06739421 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Endoscopic Treatment of Bronchial Carcinoid Tumors
NCT03723499 ·Status: COMPLETED
-
The Impact of Polynuclear Neutrophils' Intra-tumoral Rate and the Mutational Status in Pulmonary Adenocarcinomas on Survival
NCT04761640 ·Status: UNKNOWN
-
Ambispective Registry of Patients Affected by Lung Cancer
NCT07274163 ·Status: RECRUITING
-
Lung Cancer Location: a Repository
NCT00578084 ·Status: TERMINATED
-
Methylation Level of SHOX2 in Endobronchial Ultrasound With Real-time Guided Transbronchial Needle Aspiration for Lung Cancer Staging
NCT01653002 ·Status: COMPLETED
-
Diagnostic Value of Bronchoscopic and Thoracoscopic Frozen Section Biopsies in Patients With Pleuropulmonary Tumors
NCT05385419 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
NCT04202614 ·Status: COMPLETED
-
Lung Cancer Registry for Lung Cancer Patients
NCT03276429 ·Status: COMPLETED
-
Mutation Detection of EBUS-TBNA Specimens Using NGS
NCT02420405 ·Status: COMPLETED ·Phase: NA
-
Real World Registry for Use of the Ion Endoluminal System
NCT06004440 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography
NCT01347424 ·Status: UNKNOWN ·Phase: PHASE2
-
Genotyping of Ebus-tbna Supernant Cell-free Dna in Nsclc
NCT04624373 ·Status: RECRUITING
-
Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records
NCT06842056 ·Status: NOT_YET_RECRUITING
-
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
NCT00732563 ·Status: COMPLETED ·Phase: NA
-
Single Pulmonary Nodule Investigation
NCT02013063 ·Status: UNKNOWN
-
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
NCT02117440 ·Status: TERMINATED
-
Assessment of Diagnostic Yield Using a Robotic Navigational Bronchoscopy System With CBCT
NCT06084208 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer
NCT05541744 ·Status: RECRUITING